share_log

川宁生物(301301.SZ):目前没有进行抗衰老药物的研究

Twining Biotech (301301.SZ): No research on anti-aging drugs is currently being conducted

Gelonghui Finance ·  May 17 05:15

Gelonghui, May 17 丨 Chuan Ning Biology (301301.SZ) said on the investor interactive platform that the company is currently not conducting research on anti-aging drugs. In the field of biological fermentation, the company's main products include erythromycin thiocyanate intermediates, cephalosporin intermediates (7-ACA, 7-ADCA, D-7ACA), high-end cosmetic intermediates (6-APA, penicillin G potassium salt), crude ursodeoxycholic acid, coenzyme Q10 mycelium, etc.; in the field of synthetic biology, the company focuses on health product ingredients, biological pesticides, high-value added natural products, etc. Raw materials and other sectors, At present, products such as bisabolol and 5-hydroxytryptophan have been launched.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment